View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
  2. Company News
  3. Deal News
December 6, 2021updated 16 Dec 2021 9:34am

Carlyle acquires medical device contract manufacturer Resonetics

Carlyle joins existing investor GTCR as a shareholder in the medical device manufacturer Resonetics.

Funds managed by global investment firm Carlyle have bought a minority stake in medical device maker Resonetics, valuing the latter at about $2.25bn.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

Through this acquisition, Carlyle will join private equity company GTCR, an existing investor, as a shareholder in Resonetics.

Carlyle managing director and Global Healthcare head Steve Wise said: “With a long history of working alongside GTCR, we’re excited to partner with the talented Resonetics management team to accelerate the healthcare platform’s next chapter of growth.

“By leveraging Carlyle’s global network to open up new avenues of organic opportunities, such as international expansion and digitisation, as well as increasing scale through accretive acquisitions, we believe there are multiple avenues for future value creation.”

Since its inception, Carlyle has already invested more than $21bn in healthcare.

The latest investment in Resonetics is a continuation of its long-term goal of committing to healthcare.

Carlyle’s previous investments in medical product businesses include Unchained Labs, Ortho Clinical Diagnostics, MicroPort and Medline.

Founded in 1987, Resonetics manufactures solutions for the life sciences industry.

Its core capabilities include nitinol processing, thin-wall tube fabrication, centreless grinding, electropolishing, metal fabrication, photochemical machining, laser processing and fibre optic sensors.

The company also has a focus on manufacturing technical components for complex medical device applications.

It serves MedTech end-markets that include interventional cardiology, neurovascular, diabetes, ophthalmology and structural heart.

Kirkland & Ellis and Piper Sandler served as legal advisor and financial advisor, respectively, to Resonetics and GTCR for the deal.

Debevoise & Plimpton and Barclays acted as legal advisor and financial advisor, respectively, to Carlyle.

In February 2019, Resonetics acquired contract medical device manufacturer Caribou Technologies for an undisclosed amount.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network